What is Addison Disease?
Addison disease, also known as primary adrenal insufficiency, is a rare autoimmune disorder where the body’s immune system attacks and destroys the outer layer (cortex) of the adrenal glands. This destruction leads to insufficient production of essential hormones, particularly cortisol and aldosterone, which regulate metabolism, blood pressure, and the body’s response to stress. The condition affects approximately 1 in 100,000 people worldwide and can occur at any age, though it most commonly develops between ages 30-50. Early diagnosis is crucial as Addison disease can be life-threatening if left untreated, but with proper hormone replacement therapy, patients can live normal, healthy lives.
Key statistics
| ORPHA Code | 85138 |
| Prevalence | 1 in 100,000 people worldwide |
| Annual incidence | 0.8-0.9 per 100,000 people per year |
| Peak age of onset | 30-50 years |
| Gender ratio | Affects women slightly more than men (1.4:1) |
Symptoms
Early symptoms include fatigue, weakness, weight loss, low blood pressure, and salt cravings. More severe manifestations encompass muscle pain, nausea, vomiting, darkening of skin (hyperpigmentation), and potentially life-threatening adrenal crisis.
The symptoms of Addison disease develop gradually and can be easily mistaken for other conditions. Early signs include persistent fatigue that worsens over time, unexplained weight loss, muscle weakness, and low blood pressure that causes dizziness when standing. Patients often experience intense cravings for salty foods and may notice their skin becoming darker, particularly in areas of friction such as knuckles, elbows, and knees. Gastrointestinal symptoms like nausea, vomiting, and abdominal pain are common. Mood changes including depression, irritability, and difficulty concentrating frequently occur. Women may experience irregular menstrual periods. The most serious complication is adrenal crisis, characterized by severe weakness, confusion, severe abdominal or back pain, high fever, vomiting, and shock, which requires immediate emergency treatment.
Causes and risk factors
Addison disease is primarily an autoimmune condition, accounting for 80-90% of cases in developed countries. The immune system mistakenly attacks the adrenal cortex, gradually destroying the cells that produce cortisol and aldosterone. This autoimmune destruction is associated with specific antibodies, particularly 21-hydroxylase antibodies.
Secondary causes include infections such as tuberculosis (more common in developing countries), fungal infections, or HIV-related infections that damage the adrenal glands. Other causes include genetic disorders like adrenoleukodystrophy, certain medications that suppress adrenal function, hemorrhage into the adrenal glands, or cancer metastases.
Risk factors include having other autoimmune diseases such as type 1 diabetes, thyroid disorders, or vitiligo, as these conditions often cluster together in autoimmune polyglandular syndromes. Family history of autoimmune diseases also increases risk. Certain genetic variants, particularly specific HLA types, are associated with increased susceptibility to developing autoimmune Addison disease.
Prevention
Currently, there is no known way to prevent Addison disease, as it is primarily an autoimmune disorder with genetic predisposition factors beyond individual control. However, early detection through awareness of symptoms and screening in high-risk individuals can help families and healthcare providers make informed decisions. People with other autoimmune conditions or family history of autoimmune diseases should be aware of Addison disease symptoms and seek prompt medical evaluation if they develop characteristic signs. For secondary causes, prevention strategies include proper treatment of infections that can damage the adrenal glands and careful monitoring when using medications that can suppress adrenal function.
Complications
Without treatment, Addison disease is fatal. The most serious acute complication is adrenal crisis (Addisonian crisis), a life-threatening emergency that can occur during times of stress, illness, surgery, or if hormone replacement is discontinued. This crisis involves severe dehydration, shock, confusion, and can lead to coma and death within hours if untreated.
Long-term complications of untreated disease include severe electrolyte imbalances, particularly low sodium and high potassium levels, which can cause dangerous heart rhythm abnormalities. Chronic low blood pressure can lead to poor circulation and organ damage. Severe hypoglycemia (low blood sugar) can occur, particularly during fasting or stress. Even with treatment, patients face increased risk during periods of physical or emotional stress, requiring medication adjustments. Some patients may develop other autoimmune conditions as part of polyglandular autoimmune syndromes, including thyroid disease, diabetes, or premature ovarian failure.
Diagnosis
Diagnosis of Addison disease involves a combination of clinical assessment, biochemical testing, and imaging studies. The primary diagnostic test is measurement of morning cortisol levels, followed by the ACTH stimulation test (also called the synacthen test or cosyntropin stimulation test), which measures the adrenal glands’ ability to produce cortisol in response to synthetic ACTH hormone.
Blood tests reveal characteristic findings including low cortisol, elevated ACTH (adrenocorticotropic hormone), low sodium, high potassium, and sometimes elevated renin levels. Autoantibody testing, particularly for 21-hydroxylase antibodies, helps confirm autoimmune etiology. Additional tests may include measurement of other adrenal hormones like aldosterone and assessment for other autoimmune conditions.
Imaging studies such as CT or MRI of the adrenal glands can help identify structural abnormalities, infections, or tumors that might cause secondary adrenal insufficiency. In some cases, genetic testing may be recommended, particularly if hereditary causes like adrenoleukodystrophy are suspected.
Treatment
Treatment for Addison disease involves lifelong hormone replacement therapy to substitute for the hormones the adrenal glands can no longer produce adequately. The cornerstone of treatment is hydrocortisone or prednisolone to replace cortisol, typically taken 2-3 times daily with higher doses in the morning to mimic the body’s natural cortisol rhythm.
For patients with aldosterone deficiency, fludrocortisone is prescribed to help regulate salt and water balance. Patients must learn to increase their cortisol replacement during times of physical or emotional stress, illness, or before surgery. This may involve doubling or tripling the usual dose during minor illnesses or switching to injectable hydrocortisone during severe stress or inability to take oral medications.
Emergency treatment for adrenal crisis involves immediate intravenous administration of high-dose hydrocortisone, along with intravenous fluids and electrolyte replacement. All patients should carry emergency injection kits and medical alert identification. Education about stress dosing and when to seek emergency care is crucial for successful management.
Prognosis
With appropriate hormone replacement therapy, people with Addison disease can expect to live normal, full lives with near-normal life expectancy. The key to excellent outcomes is proper medication adherence, stress dose management, and regular medical follow-up.
Without treatment, Addison disease is uniformly fatal, often within months to a few years of symptom onset. However, with modern treatment approaches, the prognosis is excellent. Most patients can return to normal activities, including work, exercise, and family life. The main ongoing risks relate to adrenal crisis during times of severe stress or illness, which can be prevented through proper education and stress dose protocols.
Quality of life is generally very good with treatment, though some patients report persistent fatigue or difficulty with stress management even with optimal hormone replacement. Regular monitoring and dose adjustments can help optimize treatment outcomes.
Quality of life
Living with Addison disease requires ongoing attention to medication management and stress response, but most people adapt well and maintain excellent quality of life. Daily routines should include consistent timing of hormone replacement medications, typically with larger doses in the morning and smaller doses later in the day.
Dietary considerations include adequate salt intake, especially during hot weather or exercise, and regular meals to maintain stable blood sugar levels. Most forms of exercise are encouraged, but patients should increase medication doses for prolonged or intense physical activity. Stress management techniques such as meditation, counseling, or relaxation exercises can be beneficial.
Mental health support is important, as the diagnosis can be overwhelming and the need for lifelong medication challenging. Many patients benefit from connecting with support groups or other individuals with Addison disease. Workplace and school accommodations may include flexibility for medical appointments, access to medications during the day, and understanding about the need for stress dose adjustments during busy periods.
Travel requires careful planning, including carrying extra medications, emergency injection kits, and medical documentation. Patients should inform healthcare providers about their condition before any medical procedures or dental work.
Pregnancy and fertility
Addison disease can affect fertility, but with proper treatment, most women can conceive and have healthy pregnancies. Hormone replacement therapy is safe during pregnancy, though dose adjustments are often necessary, particularly during the third trimester when cortisol requirements increase.
Close monitoring by both endocrinologists and obstetricians is essential throughout pregnancy. Stress doses of cortisol are required during labor and delivery. The postpartum period requires careful medication adjustment as hormone needs return to pre-pregnancy levels.
Men with Addison disease may experience reduced fertility due to low testosterone levels, which can improve with proper cortisol replacement. Genetic counseling is generally not necessary for autoimmune Addison disease, as it is not directly inherited, though there may be slightly increased risk of other autoimmune conditions in offspring.
Children
Addison disease in children presents unique challenges, as symptoms may be mistaken for common childhood illnesses or behavioral issues. Growth retardation, recurrent infections, or failure to thrive may be early signs. School accommodations include ensuring access to medications, understanding about sick day management, and emergency protocols.
Pediatric dosing requires careful calculation based on body surface area, with regular adjustments as children grow. Transition to adult care typically occurs during late adolescence, requiring gradual transfer of disease management responsibilities from parents to the young adult.
Children need age-appropriate education about their condition and gradually increasing involvement in their care. Summer camps and school activities require preparation and communication with supervising adults about emergency procedures and medication administration.
When to see a doctor
Immediate emergency care is required for symptoms of adrenal crisis: severe weakness, confusion, vomiting that prevents keeping medications down, severe abdominal or back pain, high fever, or signs of shock including rapid pulse and low blood pressure. These symptoms require immediate hospital treatment with intravenous steroids and fluids.
Routine medical attention should be sought for persistent fatigue that interferes with daily activities, unexplained weight loss, muscle weakness, salt cravings, skin darkening, nausea, or low blood pressure symptoms like dizziness when standing. Early evaluation is crucial as symptoms often develop gradually and may be attributed to other causes.
Patients with diagnosed Addison disease should contact their healthcare provider for guidance on stress dosing during illnesses, before surgical procedures, or if they experience medication side effects or difficulty managing their condition.
Regional context
Limited specific data exists regarding Addison disease prevalence in the Caucasus region, though the condition likely occurs at similar rates to other populations. Autoimmune forms may be more common in populations with higher rates of other autoimmune diseases. In some areas, infectious causes such as tuberculosis may be more prevalent than in Western countries.
Healthcare infrastructure and access to hormone replacement medications may vary across the region. GMJ welcomes contributions from regional researchers to build the evidence base for Addison disease in the Caucasus, particularly regarding local prevalence, genetic factors, and healthcare delivery challenges.
Research and clinical trials
Current research focuses on improving hormone replacement regimens to better mimic natural cortisol rhythms, including modified-release hydrocortisone preparations and dual-release formulations. Scientists are investigating continuous subcutaneous hydrocortisone infusion pumps as an alternative to oral medications.
Gene therapy approaches are being explored for hereditary forms of adrenal insufficiency. Researchers are also working on biomarkers to better predict adrenal crisis risk and optimize individualized dosing strategies. Studies of adrenal regeneration and transplantation techniques offer potential future alternatives to lifelong medication.
Clinical trials information can be found at ClinicalTrials.gov, where patients can search for ongoing studies testing new treatments or improved management strategies for Addison disease.
Frequently asked questions
Can people with Addison disease live normal lives?
Yes, with proper hormone replacement therapy and education about stress management, people with Addison disease can live full, normal lives with near-normal life expectancy and excellent quality of life.
What triggers an adrenal crisis?
Adrenal crisis can be triggered by physical stress such as infections, injuries, or surgery, emotional stress, dehydration, or failure to take prescribed medications. Proper stress dosing can prevent most crises.
Is Addison disease hereditary?
The autoimmune form of Addison disease is not directly inherited, though there may be genetic susceptibility factors. Some rare genetic forms exist, but most cases occur without family history.
Can exercise and diet cure Addison disease?
No, Addison disease requires lifelong hormone replacement therapy. However, healthy diet and exercise are important for overall well-being and can help optimize treatment outcomes.
What should I do if I vomit my medications?
If vomiting prevents keeping oral medications down, emergency injection of hydrocortisone is needed, followed by immediate medical attention. All patients should have emergency injection kits available.
Support and resources
International Organizations:
– NADF (National Adrenal Diseases Foundation): nadf.us
– Addison’s Disease Self-Help Group: addisons.org.uk
– European Society of Endocrinology: ese-hormones.org
– Orphanet: orpha.net
– EURORDIS (European Rare Diseases Organisation): eurordis.org
– NORD (National Organization for Rare Disorders): rarediseases.org
Professional Resources:
– Endocrine Society: endocrine.org
– Society for Endocrinology: endocrinology.org
Related conditions
Secondary adrenal insufficiency – caused by pituitary dysfunction rather than adrenal gland destruction, with different treatment considerations.
Autoimmune polyglandular syndrome – conditions where Addison disease occurs alongside other autoimmune endocrine disorders like type 1 diabetes or thyroid disease.
Congenital adrenal hyperplasia – genetic disorders affecting adrenal hormone production that can present with similar symptoms.
Adrenoleukodystrophy – genetic condition that can cause adrenal insufficiency along with neurological symptoms.
Waterhouse-Friderichsen syndrome – acute adrenal failure typically caused by bacterial infections, particularly meningococcal disease.
Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, Endocrine Society Clinical Practice Guidelines, European Society of Endocrinology Guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.
Cite this page
GMJ News Desk. “Addison Disease.” GMJ News — Georgian Medical Journal, 1 June 2026. https://news.gmj.ge/condition/addison-disease/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?


